Studies Enrolling Volunteers
| Research Study | Eligibility | Contact Person | |
|---|---|---|---|
| Emory Alzheimer's Disease Research Center Honor Research Registry Longitudinal study of changes in memory and other cognitive skills |
| Samantha Heldenberg shelden@emory.edu 404-712-7542 | |
| ADNI-3 Alzheimer's Disease Neuroimaging Initiative |
| Jessica Swiniarski jessica.swiniarski@emory.edu | |
| AHEAD/A3-45 A 4-year infusion study to reduce amyloid accumulation as measured by PET imaging |
| Phyllis Vaughn Amber Osborne | |
| ALECTOR Evaluates the Efficacy and Safety of AL001 in Individuals at Risk for or With Frontotemporal Dementia Due to Heterozygous Mutations in the Progranulin Gene |
| Sallie Carpentier sallie.carpentier@emory.edu 404-712-4234 | |
| AUTONOMY |
| Heather Rose | |
Brewster Sleep Study |
| Baderinwa Offutt boffutt@emory.edu | |
Cognitive Empowerment Program |
| Drasti Patel | |
| DIAN CRI Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited AD |
| Courtney Williams | |
| Emory Healthy Aging Study (EHAS) Longitudinal Study of Aging Learn more about EHAS |
| Luke Maschinot luke.j.maschinot@emory.edu 404-727-1338 | |
| Emory Healthy Brain Study (EHBS) Learn more about EHBS |
| Jenny Pampalon | |
| UDALL |
| Jonna Seppa jseppa@emory.edu 404-727-1509 |
Contact Us
Please contact our clinical research coordinator for more information.
Detailed Descriptions of Research Studies and Clinical Trials
James Lah, MD, PhD
Clinical Core Leader, Emory Alzheimer's Disease Research Center
Felicia Goldstein, PhD
Clinical Core Co-Leader, Emory Alzheimer's Disease Research Center
The purpose of Honor is to have a group of volunteers who want to participate in future research studies on memory & thinking. By joining Honor you will learn about new research studies that are seeking volunteers. You will also receive our newsletter and invitations to educational events.
All Honor volunteers must have a “study partner” accompany them to their research visit. Your study partner will be asked questions about your memory and thinking. They will also be asked about your day to day functioning. A study partner is someone who has at least 10 hours of contact with you each week.
For more information about this research study, please call Samantha Heldenberg at 404-712-7542 or email shelden@emory.edu.
Allan Levey, MD, PhD
Director, Emory Alzheimer's Disease Research Center
Emory University Department of Neurology
Long-term study (2-4 years) being conducted as part of the Alzheimer’s Disease Neuroimaging Initiative to characterize changes in the brain associated with MCI and AD. Subjects will under multiple MRI and PET scans, lumbar puncture, blood draws and cognitive testing.
For more information about this research study, please call Becky Byram at 404-712-0195 or email rbyram@emory.edu.
Allan Levey, MD, PhD
This multinational study is using a placebo or the study drug, to determine safety and efficacy and to explore the dose response of this drug. In this 18-month study, a drug/placebo is infused biweekly (once every 2 weeks). Subjects will be from 2 clinical subgroups: MCI due to Alzheimer's disease (AD) or mild Alzheimer's disease dementia. Effectiveness of drug treatment will be assessed using cognitive tests, as well as biological markers (MRI, PET, CSF, blood).
For more information about this research study, please call Michelle Wiles at 404-778-0664 or email mkwiles@emory.edu.
Ihab Hajjar, MD
The study will consist of a screening period of up to 12 weeks in length following the signing of informed consent. Eligible patients will then undergo baseline visit assessments (Day 1) prior to receiving the first dose of blinded study drug (gantenerumab or placebo). Patients will continue in the double-blind treatment period for 104 weeks.
For more information about this research study, please call Aaron Milloy at 404-712-6855 or email aaron.m.milloy@emory.edu.
For more information about this research study, please call William Hu at 404-727-4174 or email wthu@emory.edu.
This study is the largest clinical research study every conducted it Atlanta. It is designed to further our scientific understanding of how we age so we can better understand, prevent and treat diseases of aging. To participate, simply sign up online at www.healthyaging.emory.edu, complete a brief health history questionnaire and occasionally respond to various surveys and complete online memory tasks.
For more information about this research study, please call Luke Maschinot at 404-727-1338 or email luke.j.maschinot@emory.edu.
Caregiving for a loved one with Alzheimer’s or another form of neurodegenerative disease is usually a new role. Some people gradually take on the role of caregiver as their spouse or parent has increasing memory or thinking problems. Others are thrust into the role. Perhaps your mother died who was caring of your father. Suddenly you become your father’s caregiver, a role for which you had no preparation.
When you have a family member with Alzheimer’s or another neurodegenerative disease there are new skills to learn and new resources that will be needed. It will be important to “plan for the future”.